Login / Signup

Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single-center long-term follow-up study.

Tomaz RusMaša PremzlNina Z KrižnarMilica G KrambergerRobert RajnarLidija OcepekZvezdan PirtošekMaja Trošt
Published in: Acta neurologica Scandinavica (2022)
AEs related to LCIG treatment are common. Therefore, careful patient selection and monitoring throughout the treatment is recommended, especially in those with early side effects. Nevertheless, LCIG significantly improves HRQoL in advanced PD patients on a long term.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • combination therapy
  • prognostic factors
  • deep brain stimulation
  • parkinson disease